Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 16/20 | 0.62 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3788978 | 0.93 | PIK3CA (0.61) | PIK3CACREBBPHDAC3HDAC1HDAC2 | |
| SCHEMBL3795779 | 0.92 | PIK3CA (0.60) | PIK3CACREBBPBCHEACHE | |
| SCHEMBL3793252 | 0.91 | PIK3CA (0.62) | PIK3CACREBBP | |
| SCHEMBL3799035 | 0.89 | PIK3CA (0.61) | PIK3CACREBBP | |
| SCHEMBL3794536 | 0.89 | PIK3CA (0.64) | PIK3CACREBBP | |
| SCHEMBL3796011 | 0.89 | PIK3CA (0.66) | PIK3CACREBBP | |
| SCHEMBL3794123 | 0.89 | PIK3CA (0.64) | PIK3CACREBBP | |
| SCHEMBL2725831 | 0.89 | PIK3CA (0.64) | PIK3CACREBBP | |
| SCHEMBL14960370 | 0.88 | PIK3CA (0.56) | PIK3CACREBBPBCHEACHE | |
| SCHEMBL3796348 | 0.88 | PIK3CA (0.61) | PIK3CACREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010138490-A1 | BENZOXAZEPINES AS INHIBITORS OF MTOR AND METHODS OF THEIR USE AND MANUFACTURE | EXELIXIS, INC. (US) | 2010-12-02 | — | — | WO | disclosed |